Literature DB >> 19515849

Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems.

Aurélie Dipietromaria1, Bérénice A Benayoun, Anne-Laure Todeschini, Isabelle Rivals, Claude Bazin, Reiner A Veitia.   

Abstract

Mutations of FOXL2 are responsible for the Blepharophimosis-Ptotsis-Epicantus-inversus Syndrome (BPES), involving complex eyelid malformations often associated with premature ovarian failure (POF). Loss-of-function mutations are expected to lead to BPES associated with POF, whereas hypomorphic mutations would lead to BPES without ovarian dysfunction. However, multiple exceptions to the genotype-phenotype correlation have been described and missense mutations in the forkhead domain can lead to either type of BPES. This renders almost impossible the prediction of a POF condition from a given genotype. Moreover, no clear-cut correlation between nuclear and/or cytoplasmic aggregation or cytoplasmic retention of mutant FOXL2 forms and the BPES type has been established thus far. Here, we dissect the molecular and functional effects of 10 FOXL2 mutants, known to induce BPES associated with POF or not. We found a correlation between the transcriptional activity of FOXL2 variants on two different reporter promoters and the type of BPES. We used this functional classification framework to explore the behavior of 18 missense mutations leading to BPES of unknown type. The reporters used enabled us to assess the risk of POF associated with these mutations. Moreover, we document a previously overlooked correlation between subcellular mislocalization and aggregation of mutant FOXL2 and the type of BPES, known or predicted using our reporter assays. Thus, intranuclear aggregation and cytoplasmic mislocalization of mutant FOXL2 may be considered as loose predictors of ovarian dysfunction. The functional classification tool described here is a first step towards circumventing the lack of a clear-cut genotype-phenotype correlation in BPES.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19515849     DOI: 10.1093/hmg/ddp273

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

1.  Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.

Authors:  S Nuovo; M Passeri; E Di Benedetto; M Calanchini; I Meldolesi; M C Di Giacomo; D Petruzzi; M R Piemontese; L Zelante; F Sangiuolo; G Novelli; A Fabbri; F Brancati
Journal:  J Endocrinol Invest       Date:  2015-06-23       Impact factor: 4.256

Review 2.  Minireview: Activin Signaling in Gonadotropes: What Does the FOX say… to the SMAD?

Authors:  Jérôme Fortin; Luisina Ongaro; Yining Li; Stella Tran; Pankaj Lamba; Ying Wang; Xiang Zhou; Daniel J Bernard
Journal:  Mol Endocrinol       Date:  2015-05-05

3.  Aberrant and constitutive expression of FOXL2 impairs ovarian development and functions in mice.

Authors:  Barbara Nicol; Karina Rodriguez; Humphrey H-C Yao
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

4.  Insights into the pathogenicity of missense variants in the forkhead domain of FOX proteins underlying Mendelian disorders.

Authors:  Luis Bermúdez-Guzmán; Reiner A Veitia
Journal:  Hum Genet       Date:  2021-02-27       Impact factor: 4.132

5.  Granulosa cell tumor mutant FOXL2C134W suppresses GDF-9 and activin A-induced follistatin transcription in primary granulosa cells.

Authors:  Kirsten J McTavish; David Nonis; Yvonne D Hoang; Shunichi Shimasaki
Journal:  Mol Cell Endocrinol       Date:  2013-04-06       Impact factor: 4.102

6.  A novel FOXL2 mutation in two infertile patients with blepharophimosis-ptosis-epicanthus inversus syndrome.

Authors:  Jingmei Hu; Hanni Ke; Wei Luo; Yajuan Yang; Hongli Liu; Guangyu Li; Yingying Qin; Jinlong Ma; Shidou Zhao
Journal:  J Assist Reprod Genet       Date:  2019-12-10       Impact factor: 3.412

7.  FOXL2C134W-Induced CYP19 Expression via Cooperation With SMAD3 in HGrC1 Cells.

Authors:  Martina Belli; Nahoko Iwata; Tomoko Nakamura; Akira Iwase; Dwayne Stupack; Shunichi Shimasaki
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

8.  Missense mutation outside the forkhead domain of FOXL2 causes a severe form of BPES type II.

Authors:  Alireza Haghighi; Hannah Verdin; Hamidreza Haghighi-Kakhki; Niloofar Piri; Nasrollah Saleh Gohari; Elfride De Baere
Journal:  Mol Vis       Date:  2012-01-26       Impact factor: 2.367

9.  Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Authors:  Bérénice A Benayoun; Sandrine Caburet; Aurélie Dipietromaria; Adrien Georges; Barbara D'Haene; P J Eswari Pandaranayaka; David L'Hôte; Anne-Laure Todeschini; Sankaran Krishnaswamy; Marc Fellous; Elfride De Baere; Reiner A Veitia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

10.  Differential apoptotic and proliferative activities of wild-type FOXL2 and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES)-associated mutant FOXL2 proteins.

Authors:  Jae-Hong Kim; Jeehyeon Bae
Journal:  J Reprod Dev       Date:  2013-11-15       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.